Clinical Trial Update: Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the value of immediate post-operative intravesical epirubicin in intermediate- and high-risk non-muscle invasive bladder can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Epirubicin (epirubicin)

Snippet

Sponsor: Mansoura University | Conditions: Carcinoma of Urinary Bladder, Superficial | Phase 4 | Status: COMPLETED